Healthcare professionals

AfA is here to help you care for and manage patients living with HIV/AIDS. Access our team of clinical HIV experts to get support, ask for advice and discuss complex clinical challenges. Explore our protocols, guidelines, publications and clinical intelligence.


CPD online training

Gain HIV management skills.

Online modular training for doctors and other healthcare professionals in HIV medicine offers a practical solution to gain HIV management skills. It is particularly suitable for those working outside of the major centres.

You can complete individual modules or the full training programme.

  • The modules cover the basics of HIV management and reflect current best practice, both nationally and internationally.
  • Each module is CPD-accredited with a CPD certificate issued online following successful answering of several multiple-choice questions.
  • All the modules will be updated annually.
  • There will be a dedicated annual HIV update module based on new guidelines and advances in HIV management.

Registration on the course is free of charge and is open to all doctors as well as other interested healthcare professionals.

Please go here to register, using your professional council registration number, and follow the simple instructions. If you do not have a professional council number your ID number may be used.

The course has been developed by Professor Gary Maartens, who is an acknowledged expert in HIV management and has participated in the development of HIV treatment guidelines both nationally and internationally. He has been involved in teaching and research in HIV medicine for many years and has been a senior consultant on the AfA Clinical Advisory Committee since its inception in 1998.

Publications and Presentations

AfA has spoken at and participated in local and international conferences, had its collaborative research published and been invited to speak at a variety of organisations. Our approach is to share our expertise on the clinical, programmatic and behavioural aspects of managing HIV in different settings freely.


July 2007

  • The use of Tenofovir Disoproxil Fumarate (TDF) in HAART regimens
  • Resistance patterns associated with decreased Tenofovir efficacy
  • Emtricitabine (FTC)
  • Tenofovir: side effects and toxicities
  • Hepatitis B
  • The use of Tenofovir in pregnancy and in paediatric patients
  • Monitoring patients on Tenofovir
  • Viread® and Truvada®
  • Tenofovir drug interactions

March 2007

  • Contraception and antiretroviral therapy
  • Monitoring lipids and glucose
  • The SMART study
  • Breast feeding in HIV-infected and exposed infants – paradigm shift
  • Antiretroviral therapeutic drug monitoring
  • Monitoring and promoting adherence to therapy with courier pharmacies

December 2006

  • Dose of Stavudine
  • Patients who switch to Nevirapine with higher CD4 counts are not at increased risk of hepatotoxicity
  • Antiretroviral resistance testing
  • Routine testing for HIV infection
  • Post-exposure prophylaxis (PEP) – remember to assess the risks and benefits
  • Pneumococcal vaccine for Children

June 2006

  • Breastfeeding in HIV-infected Infants
  • Triomune-40 tablets are available
  • Referring patients to public sector ARV Clinics
  • Bacterial Pneumonia in HIV+ Adults
  • Using Kaletra with Rifampicin

June 2006

  • Pro forma letter

October 2005

  • Management of patients with Myperlactataemia / Lactic Acidosis
  • Doses in Renal Failure
  • Enteric-coated Videx capsules available
  • HAART Hypertension

June 2005

  • New AfA guidelines for initiating HAART in adults
  • Management of isolated elevated Gamma Glutamyl Transpeptidase (GGT) levels in HIV
  • WHO Clinical Stage III and IV conditions
  • Treating PCP in patients who are allergic to Cotrimoxazole
  • AfA clinical guildelines – 5th Edition

February 2005

  • Management of HIV – associated Kaposi’s Sarcoma (KS)
  • Generic antiretrovirals ARVs)
  • Scheme changes for 2005
  • FDA public health advisory for Nevirapine

August 2004

  • WHO clinical staging
  • The role of Tenofovir DF (Viread)
  • Protease inhibitor-induced diarrhoea
  • Benefit booking
  • Making major decisions on CD4+ counts
  • Tuberculosis and ART
  • Generic antiretrovirals

April 2004

  • Nevirapine and pregnancy – new concerns
  • Immune ‘boosters’ in HIV infection
  • AfA and generic antiretroviral agents
  • Increase in 0199 payment
  • Scheme changes for 2004
  • Kaletra and Rifampicin
  • HAART and Porphyria

November 2003

  • Voluntary counselling and testing
  • Non-nucleoside reverse transcriptase inhibitor in the internal regimen
  • AfA and generic antiretroviral agents
  • Death knell for structured treatment interruptions
  • The Medscheme price list (MPL)

August 2003

  • New AfA criteria for initiating ART
  • Pharmaceutical courier services
  • ICU management of HIV patients
  • HIV rapid testing